Corrigendum [0.03%]
勘误表
Published Erratum
Anticancer research. 2026 Feb;46(2):1173. DOI:10.21873/anticanres.18020 2026
Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine Dependence [0.03%]
甲硫氨酸依赖而非谷氨酰胺依赖是癌细胞的特异性脆弱性
Yuta Miyashi,Kohei Mizuta,Yohei Asano et al.
Yuta Miyashi et al.
Background/aim: Glutamine (GLN) addiction has been proposed as a cancer vulnerability and a therapeutic target. However, the glutamine requirement of normal cells is poorly understood. In the present study, we used a uniq...
Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance Status [0.03%]
MET-TKIs治疗MET外显子14跳变伴较差体能状况的非小细胞肺癌的临床疗效
Yoh Yamaguchi,Tatsuya Yoshida,Ryoko Inaba Higashiyama et al.
Yoh Yamaguchi et al.
Background/aim: The mesenchymal-epithelial transition (MET) receptor plays a key role in cell growth and survival. The MET exon 14 (METex14) skipping mutation occurs in 3% to 4% of patients with non-small cell lung cancer...
mTOR Modulation Affects Galectin-1 Expression in KMT2A-rearranged Acute Lymphoblastic Leukemia Cells [0.03%]
mTOR调节影响KMT2A重排急性淋巴细胞白血病细胞中Galectin-1的表达
Bartłomiej Pawlik,Joanna Madzio,Zuzanna Rydzyńska et al.
Bartłomiej Pawlik et al.
Background/aim: Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Among its genetic subtypes, KMT2A (formerly MLL)-rearranged ALL (KMT2Ar-ALL) is associated with poor outcomes. Immunotherapy appr...
Early Predictive Factors for Severe Postoperative Complications Following Major Liver and Pancreatic Surgery [0.03%]
肝切除和胰腺手术后严重并发症早期预测因素分析
Masahiro Fukada,Noriki Mitsui,Takeshi Horaguchi et al.
Masahiro Fukada et al.
Background/aim: Postoperative severe complications (PSC) are key indicators of surgical quality because they increase healthcare costs, delay adjuvant chemotherapy, and impair long-term survival. Hepato-biliary-pancreatic...
First-Line Afatinib 30 mg Versus 40 mg in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutations: Real-world Efficacy and Tolerability in Taiwan [0.03%]
台湾罕见EGFR突变非小细胞肺癌患者一线使用阿法替尼30毫克与40毫克的疗效和安全性研究
Hui-Yang Hung,Tai-Huang Lee,Cheng-Hao Chuang et al.
Hui-Yang Hung et al.
Background/aim: Afatinib is an irreversible EGFR-TKI effective against uncommon EGFR mutations in non-small cell lung cancer (NSCLC), but the influence of mutation subtype and starting dose on treatment outcomes remains u...
Selective Inhibition of Protein Kinase D2 Activity Reduces Human Neutrophil Survival [0.03%]
选择性抑制蛋白激酶D2活性可减少人中性粒细胞的存活率
Noriko Uchiyama
Noriko Uchiyama
Background/aim: Small molecule anti-cancer drugs can cause adverse effects; most commonly low blood cell counts. Protein kinase D2 (PKD2) is highly expressed in neutrophils, and this study investigated the role of PKD2 in...
Awareness, Utilization, and Barriers to Fluorescence Ureteral Navigation in Japan: A Nationwide Survey Study [0.03%]
日本荧光尿道导航的意识、利用及障碍的全国调查研究
Shunjin Ryu,Yuta Imaizumi,Shunsuke Nakashima et al.
Shunjin Ryu et al.
Background/aim: Fluorescence ureteral navigation (FUN) using near-infrared devices (e.g., NIRC™ and IRIS) can assist in the visualization of ureters and the prevention of iatrogenic injury during complex colorectal proce...
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase In Vitro [0.03%]
AG-270选择性甲硫氨酸腺苷转移酶2A(MAT2A)抑制剂联合重组methioninase体外非特异性研究
Jinsoo Kim,Qinghong Han,Shukuan Li et al.
Jinsoo Kim et al.
Background/aim: Methionine addiction is a fundamental and general hallmark of cancer termed the Hoffman effect. Methionine restriction using recombinant methioninase (rMETase) has shown synergistic efficacy with numerous ...
Short- and Long-term Results of Complete Resection and Vascular Reconstruction for Infrahepatic Inferior Vena Cava Leiomyosarcomas: A Retrospective Case Series of 33 Patients [0.03%]
腔静脉切除重建治疗肝后下腔静脉平滑肌肉瘤的短期和长期疗效回顾性研究(33例)
Priscilla Nardi,Valerio Rinaldi,Valeria Iacoucci et al.
Priscilla Nardi et al.
Background/aim: Inferior vena cava (IVC) leiomyosarcoma is a rare malignant tumor, with fewer than 500 cases described in literature. Prognosis is poor, and radical surgical resection remains the gold standard of treatmen...